跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 249 条关于
“Woori IO”
全部
249
临床试验
89
药物
48
机构
3
资讯
109
去年
OSR Holdings Acquires Korean Non-Invasive Glucose Monitoring Pioneer Woori IO
2年前
Comparing Long-Term Data for IO/IO and IO/TKI in Favorable-Risk Metastatic Renal Cell Carcinoma
去年
Nivolumab Plus Ipilimumab Shows Durable Survival Benefit in Advanced RCC
去年
IO Biotech Faces Nasdaq Delisting Risk Despite Promising Cancer Vaccine Advances
去年
IO Biotech Phase 3 Trial Fails to Meet Primary Endpoints
去年
IO-202 Plus Azacitidine Shows Promise in Treating CMML
2年前
ESMO 2024: Optimizing Post-IO Therapy in Clear Cell and Expanding Options for Non-Clear Cell RCC
去年
IO Biotech's Cylembio Cancer Vaccine Misses Primary Endpoint in Phase 3 Melanoma Trial
11个月前
IO Biotech Cuts Workforce by 50% Following FDA Rejection of Cancer Drug Application
8个月前
IO Biotech Explores Strategic Alternatives as Cancer Vaccine Developer Faces Financial Pressures
第 1 页,共 11 页
上一页
下一页